Navigation Links
Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2009 Financial Results
Date:11/2/2009

ARDEE, Ireland, Nov. 2 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it will issue its third quarter 2009 financial results prior to the market opening on Monday, November 9, 2009.

In addition to issuing a press release, the Company will host a conference call for all interested parties on Monday, November 9, 2009 at 8:00 AM (Eastern Time) to review the results. To participate in the call, please dial (888) 812-8595 in the United States and Canada or (913) 312-0645 internationally.

Investors and other interested parties may also access the conference call via a simultaneous audio webcast by visiting http://ir.wcrx.com and clicking on Events & Presentations.

A replay of the conference call will be available for two weeks following the call and can be accessed by dialing (888) 203-1112 within the United States and Canada or (719) 457-0820 internationally. The passcode for the replay is 8954946.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, dermatology and urology segments of the U.S. and Western European pharmaceuticals market. It is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-F

SOURCE Warner Chilcott plc


'/>"/>
SOURCE Warner Chilcott plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents
2. Video: U.S. Department of Health and Human Services Joins Ad Council and Warner Bros. Pictures to Combat Childhood Overweight and Obesity
3. Warner Chilcott Acquires P&Gs Global Pharmaceuticals Business
4. Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance
5. Warner Chilcott Announces Receipt of Paragraph IV Certification Notices
6. Warner Chilcott Announces Earnings Release Date and Conference Call For Second Quarter 2009 Financial Results
7. Warner Chilcott to Hold 2009 Annual General Meeting of Shareholders and Special Court-Ordered Meeting of Shareholders
8. Warner Chilcott to Present at Wachovias 19th Annual Mid-Year Equity Conference
9. Senators Webb and Warner Vote to Protect Americas Kids From Tobacco
10. Warner Chilcott to Present at the Goldman Sachs 30th Annual Healthcare Conference
11. Warner Chilcott Announces FDA Acceptance of NDA Submission for Low Dose Oral Contraceptive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... 23, 2017 , ... The Wound Certification Prep Course ... Holdings, LLC, today announced that RestorixHealth® has officially endorsed WCPC as ... interested in becoming Certified Wound Specialist Physicians (CWSP®). , This collaborative effort ...
(Date:3/23/2017)... ... March 23, 2017 , ... Altec Products, Inc. , ... as their 2016 Microsoft Dynamics Partner of the Year at DocLink Evolution ... award recognizes The Resource Group for their outstanding relationship with Altec and their ...
(Date:3/23/2017)... FL (PRWEB) , ... March 23, 2017 , ... ... dietary supplements that help improve all aspects of people’s health and nutrition, announced ... for nutritional products. , Natural Subsistence develops nutritional supplements that help people ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... all Americans facing life-altering and fatal diseases in opposition to the President’s ... that would eviscerate care, services, and hope for the most vulnerable among us. ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... audit software solution, iCode Assurance, at HCCA’s 21st annual Compliance Institute on March ... the coding audit process for all medical chart types with a comprehensive set ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 2017  Ethicon* today announced the completion of ... held medical device company that manufactures and markets ... treatment of Gastroesophageal Reflux Disease (GERD). This acquisition ... portfolio of minimally invasive options for patients suffering ... of the transaction have not been disclosed. ...
(Date:3/23/2017)... A research report by Mordor Intelligence ... reach USD 7.2 billion by the end of 2021 and ... procedure in which a sample is preserved prior to its ... since the methods are often allowing repeated testing. The report ... shared procedures in the lab. In many life science labs, ...
(Date:3/23/2017)... 2017  Drug diversion is a significant contributing ... overdoses. A new oral fluid monitoring test, announced ... reports more detailed and actionable information to clinicians ... therapy adherence, patient safety, and help to identify ... fluid Rx Evaluation (CORE) system is the first ...
Breaking Medicine Technology: